HomePMCB • NASDAQ
add
Pharmacyte Biotech Inc
Previous close
$0.84
Day range
$0.75 - $0.86
Year range
$0.63 - $1.90
Market cap
7.79M USD
Avg Volume
6.89M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Oct 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.38M | 24.41% |
Net income | -7.42M | -404.78% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Oct 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.61M | -1.12% |
Total assets | 55.98M | 1.59% |
Total liabilities | 19.42M | 66.76% |
Total equity | 36.55M | — |
Shares outstanding | 10.13M | — |
Price to book | 0.16 | — |
Return on assets | -6.81% | — |
Return on capital | -8.58% | — |
Cash Flow
Net change in cash
| (USD) | Oct 2025info | Y/Y change |
|---|---|---|
Net income | -7.42M | -404.78% |
Cash from operations | -979.52K | 7.13% |
Cash from investing | -3.00M | — |
Cash from financing | 6.21M | 157.80% |
Net change in cash | 2.23M | 118.89% |
Free cash flow | -1.64M | 53.43% |
About
Founded
1996
Headquarters
Website
Employees
2
